Empowered Funds LLC increased its position in shares of MetLife, Inc. (NYSE:MET – Free Report) by 8.2% during the third quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 10,408 shares of the financial services provider’s stock after buying an additional 788 shares during the quarter. Empowered Funds LLC’s holdings in MetLife were worth $858,000 at the end of the most recent quarter.
Several other institutional investors and hedge funds have also recently added to or reduced their stakes in the company. MeadowBrook Investment Advisors LLC lifted its position in MetLife by 244.4% in the third quarter. MeadowBrook Investment Advisors LLC now owns 310 shares of the financial services provider’s stock worth $26,000 after purchasing an additional 220 shares during the period. Carmichael Hill & Associates Inc. raised its stake in shares of MetLife by 131.9% in the 3rd quarter. Carmichael Hill & Associates Inc. now owns 327 shares of the financial services provider’s stock valued at $27,000 after buying an additional 186 shares in the last quarter. Wolff Wiese Magana LLC lifted its holdings in shares of MetLife by 374.3% during the 3rd quarter. Wolff Wiese Magana LLC now owns 351 shares of the financial services provider’s stock worth $29,000 after acquiring an additional 277 shares during the period. Fortitude Family Office LLC boosted its position in shares of MetLife by 177.3% during the 3rd quarter. Fortitude Family Office LLC now owns 416 shares of the financial services provider’s stock valued at $34,000 after acquiring an additional 266 shares in the last quarter. Finally, Venturi Wealth Management LLC increased its stake in MetLife by 37.0% in the third quarter. Venturi Wealth Management LLC now owns 533 shares of the financial services provider’s stock valued at $44,000 after acquiring an additional 144 shares during the period. 89.81% of the stock is currently owned by institutional investors.
Analyst Upgrades and Downgrades
A number of equities research analysts have weighed in on MET shares. Morgan Stanley decreased their price objective on MetLife from $86.00 to $85.00 and set an “overweight” rating on the stock in a report on Monday, August 19th. Jefferies Financial Group upped their price target on MetLife from $89.00 to $95.00 and gave the company a “buy” rating in a research report on Friday, September 27th. Wells Fargo & Company lifted their price objective on MetLife from $92.00 to $93.00 and gave the company an “overweight” rating in a report on Tuesday, November 5th. StockNews.com upgraded MetLife from a “hold” rating to a “buy” rating in a research report on Tuesday, November 12th. Finally, Barclays lowered their target price on MetLife from $91.00 to $90.00 and set an “overweight” rating for the company in a research note on Thursday, October 31st. Fourteen analysts have rated the stock with a buy rating, According to data from MarketBeat, the stock has a consensus rating of “Buy” and a consensus target price of $88.46.
MetLife Stock Up 1.7 %
Shares of NYSE:MET opened at $86.60 on Friday. MetLife, Inc. has a one year low of $62.81 and a one year high of $86.94. The stock has a market cap of $59.96 billion, a price-to-earnings ratio of 17.46, a P/E/G ratio of 0.75 and a beta of 1.05. The company has a debt-to-equity ratio of 0.51, a current ratio of 0.16 and a quick ratio of 0.16. The company has a 50 day moving average of $82.48 and a 200-day moving average of $76.02.
MetLife Dividend Announcement
The business also recently declared a quarterly dividend, which will be paid on Monday, December 16th. Stockholders of record on Tuesday, November 5th will be given a $0.545 dividend. The ex-dividend date is Tuesday, November 5th. This represents a $2.18 annualized dividend and a dividend yield of 2.52%. MetLife’s dividend payout ratio is currently 43.95%.
About MetLife
MetLife, Inc, a financial services company, provides insurance, annuities, employee benefits, and asset management services worldwide. It operates through six segments: Retirement and Income Solutions; Group Benefits; Asia; Latin America; Europe, the Middle East and Africa; and MetLife Holdings. The company offers life, dental, group short-and long-term disability, individual disability, pet insurance, accidental death and dismemberment, vision, and accident and health coverages, as well as prepaid legal plans; administrative services-only arrangements to employers; and general and separate account, and synthetic guaranteed interest contracts, as well as private floating rate funding agreements.
See Also
- Five stocks we like better than MetLife
- Why Invest in 5G? How to Invest in 5G Stocks
- Tesla Investors Continue to Profit From the Trump Trade
- Best Stocks Under $5.00
- MicroStrategy’s Stock Dip vs. Coinbase’s Potential Rally
- What is an Earnings Surprise?
- Netflix Ventures Into Live Sports, Driving Stock Momentum
Want to see what other hedge funds are holding MET? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for MetLife, Inc. (NYSE:MET – Free Report).
Receive News & Ratings for MetLife Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MetLife and related companies with MarketBeat.com's FREE daily email newsletter.